Correction: Efficacy and Safety in a 4-year Follow-up of the ELEVATE-TN Study Comparing Acalabrutinib with or Without Obinutuzumab Versus Obinutuzumab Plus Chlorambucil in Treatment-naïve Chronic Lymphocytic Leukemia